Dr. David F Mobley , MD
Urology • Houston, TX
18300 Katy Fwy, Suite 325
Houston, TX 770941385
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 15, 2005; this date does not establish years in practice.
-
Published CMS data list 1,512 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 749 service units.
- 51798 — Ultrasound measurement of bladder capacity after voiding: 210 service units.
- 99214 — Established patient outpatient office visit: 154 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 10 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,895 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 862 prescription fills, including refills.
- Finasteride — 615 prescription fills, including refills.
- Alfuzosin Hcl Er (Alfuzosin Hcl) — 560 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 65% of clinicians listed under Urology in Houston, TX (2024, 111 clinicians with data). Median for this group: 895. Middle half: 307 to 3,260.
Close to the middle for Medicare Part B services among clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,652 in 2020 to 1,512 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
18300 Katy Fwy
Suite 325
Houston, TX 770941385
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Houston Methodist Specialty Physicians; Tmh Physician Associates Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Tennessee, Hsc, College Of Medicine
1968
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
787 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $129,196 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $87,858 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
10,178 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$665,890 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,018.45 across 37 records.
By nature of payment
- Food and Beverage: $1,086.05 across 36 records.
- Consulting Fee: $932.40 across 1 record.
Reporting-company totals (3 largest of 17)
- Edap Technomed Inc: $932.40 across 1 record.
- Boston Scientific Corporation: $239.60 across 4 records.
- Pfizer Inc.: $150.14 across 5 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
58 years (graduated 1968)
CMS Doctors and Clinicians data list 1968 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Mobley has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Mobley as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 65% of clinicians listed under Urology in Houston, TX (2024, 111 clinicians with data). Median for this group: 895. Middle half: 307 to 3,260.
Close to the middle for clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Medicare-allowed amount
A higher Medicare-allowed amount than 60% of clinicians listed under Urology in Houston, TX (2024, 111 clinicians with data). Median for this group: $90,522. Middle half: $36,972 to $190,478.
Close to the middle for clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $130,907. Middle half: $56,287 to $242,595.
Paid by Medicare
A higher Medicare payment amount than 60% of clinicians listed under Urology in Houston, TX (2024, 111 clinicians with data). Median for this group: $63,742. Middle half: $25,609 to $144,495.
Close to the middle for clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $98,400. Middle half: $41,252 to $185,944.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Urology in Houston, TX (2024, 123 clinicians with data). Median for this group: 840. Middle half: 168 to 2,301.
More Part D prescriptions than 90% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Urology in Houston, TX (2024, 123 clinicians with data). Median for this group: $122,097. Middle half: $5,939 to $231,314.
A higher Part D drug cost than 85% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
181 active clinicians are listed under Urology with a practice address in Houston, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
42.5% of these 181 clinicians have the CMS telehealth indicator.
70.2% of these 181 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 1,652 in 2020 and 1,512 in 2024.
- 2020: 1,652
- 2021: 1,575
- 2022: 1,571
- 2023: 1,436
- 2024: 1,512
-
Medicare-allowed amount
Medicare-allowed amount stayed about the same: $125,417 in 2020 and $129,196 in 2024.
- 2020: $125,417
- 2021: $139,264
- 2022: $145,591
- 2023: $132,326
- 2024: $129,196
-
Paid by Medicare
Paid by Medicare stayed about the same: $84,583 in 2020 and $87,858 in 2024.
- 2020: $84,583
- 2021: $95,642
- 2022: $98,502
- 2023: $89,584
- 2024: $87,858
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 20% from 3,256 in 2020 to 3,895 in 2024.
- 2020: 3,256
- 2021: 3,356
- 2022: 3,557
- 2023: 3,739
- 2024: 3,895
-
30-day fills
30-day fills increased 31% from 7,758 in 2020 to 10,178 in 2024.
- 2020: 7,758
- 2021: 8,282
- 2022: 8,733
- 2023: 9,277
- 2024: 10,178
-
Part D drug cost
Part D drug cost increased 138% from $280,131 in 2020 to $665,890 in 2024.
- 2020: $280,131
- 2021: $258,733
- 2022: $279,559
- 2023: $264,724
- 2024: $665,890
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $390.13 in 2021 to $2,018.45 in 2025.
- 2021: $390.13
- 2022: $1,476.17
- 2023: $9,843.12
- 2024: $1,583.66
- 2025: $2,018.45
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 37 records totaling $2,018.45.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Edap Technomed Inc |
Consulting Fee
Cash or cash equivalent
|
Focal One | General | $932.40 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $142.78 |
| BIOTISSUE HOLDINGS INC. |
Food and Beverage
In-kind items and services
|
— | General | $90.49 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $84.35 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $34.38 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $33.34 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $30.71 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rivfloza | General | $29.74 |
| Ethicon Inc. |
Food and Beverage
In-kind items and services
|
SURGIFLO Hemostatic Matrix | General | $29.58 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $28.80 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $27.54 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.11 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $26.90 |
| Ethicon Inc. |
Food and Beverage
In-kind items and services
|
ETHICON | General | $26.86 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $25.28 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $24.74 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $24.62 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $24.17 |
| COLOPLAST CORP |
Food and Beverage
In-kind items and services
|
Altis | General | $24.07 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $23.96 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $23.82 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $22.56 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $22.39 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $22.19 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
JATENZO | General | $21.90 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
749 | 596 | $212.00 | $91.34 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
210 | 196 | $112.00 | $11.29 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
154 | 138 | $314.00 | $129.00 |
|
96372
Injection of drug or substance under skin or into muscle
|
105 | 11 | $97.00 | $14.30 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
83 | 83 | $483.00 | $168.85 |
|
J0278
Injection, amikacin sulfate, 100 mg
|
78 | 25 | $4.00 | $0.80 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
46 | 46 | $317.00 | $112.64 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
33 | 28 | $1081.00 | $238.90 |
|
55700
Biopsy of prostate gland
|
27 | 27 | $1186.00 | $234.38 |
|
76872
Ultrasound scan of pelvic region through rectum
|
27 | 27 | $498.00 | $132.34 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 862 | 74,953 | $14,245.34 | 282 |
| Finasteride | Finasteride | 615 | 54,465 | $9,557.01 | 185 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 560 | 48,776 | $14,069.54 | 182 |
| Doxazosin Mesylate | Doxazosin Mesylate | 333 | 28,645 | $5,965.66 | 101 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 332 | 27,831 | $9,809.43 | 134 |
| Testosterone Cypionate | Testosterone Cypionate | 186 | 11,779 | $9,877.62 | 58 |
| Myrbetriq | Mirabegron | 126 | 7,775 | $113,281.25 | 41 |
| Dutasteride | Dutasteride | 124 | 11,054 | $2,786.94 | 40 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 111 | 715 | $448.19 | 86 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 107 | 8,188 | $3,510.23 | 40 |
| Testosterone | Testosterone | 80 | 2,375 | $7,281.29 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 48 | 555 | $227.90 | 34 |
| Silodosin | Silodosin | 44 | 3,856 | $4,885.95 | 18 |
| Gemtesa | Vibegron | 44 | 1,800 | $27,861.67 | 12 |
| Metronidazole | Metronidazole | 38 | 116 | $193.71 | 35 |
| Desmopressin Acetate | Desmopressin Acetate | 36 | 2,505 | $1,745.87 | 13 |
| Terazosin Hcl | Terazosin Hcl | 34 | 3,060 | $630.79 | — |
| Solifenacin Succinate | Solifenacin Succinate | 34 | 2,675 | $3,121.45 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 271 | $487.60 | 19 |
| Xtandi | Enzalutamide | 25 | 750 | $409,090.66 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 160 | $160.35 | 15 |
| Mirabegron Er | Mirabegron | 17 | 1,290 | $11,604.60 | — |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | 348 | $159.79 | — |
| Xyosted | Testosterone Enanthate | 16 | 448 | $9,487.36 | — |
| Cabergoline | Cabergoline | 15 | 1,236 | $2,117.26 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20050413000153
TX
3577500313
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Houston Methodist Specialty Physicians
6445 Main St, Houston, TX 770301502
Phone: 7134413150
Tmh Physician Associates Pllc
7575 San Felipe St, Houston, TX 770631777
Phone: 7132669955
Tmh Physician Associates Pllc
18500 Katy Fwy, Houston, TX 770941110
Phone: 8325228560
Tmh Physician Associates Pllc
4710 Bellaire Blvd, Bellaire, TX 774014505
Phone: 7133639411
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 18300 KATY FWY, SUITE 325, HOUSTON, TX 770941385 (Tel: 8325228300)
Registered at 18300 KATY FWY, SUITE 325, HOUSTON, TX 770941385 (Tel: 8325228300)
Recorded as DAVID MOBLEY, M.D.
Specialist (license number reported to NPPES: TX D6666)
Record officially reactivated for active practice on March 27, 2006
NPPES lists this NPI as deactivated as of March 22, 2006; the reason is not published.
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Houston
- Dr. Seth Lerner, MD
- Dr. Gregory Hester, MD
- Dr. Julie Stewart, MD
- Dr. Tung Shu, MD
- Dr. Ruiyang Jiang, MD
- Dr. Elizabeth Ellis, MD
Mailing Address
18300 Katy Fwy, Suite 325
Houston, TX 770941385
Phone: 8325228300